These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 19204155)

  • 1. A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease.
    Xia W; Yang T; Shankar G; Smith IM; Shen Y; Walsh DM; Selkoe DJ
    Arch Neurol; 2009 Feb; 66(2):190-9. PubMed ID: 19204155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.
    Ikonomovic MD; Wecker L; Abrahamson EE; Wuu J; Counts SE; Ginsberg SD; Mufson EJ; Dekosky ST
    Arch Neurol; 2009 May; 66(5):646-51. PubMed ID: 19433665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity.
    Pyun JM; Ryu JS; Lee R; Shim KH; Youn YC; Ryoo N; Han SW; Park YH; Kang S; An SSA; Kim S
    Clin Interv Aging; 2021; 16():749-755. PubMed ID: 33958861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer's disease.
    Meng X; Li T; Wang X; Lv X; Sun Z; Zhang J; Su F; Kang S; Kim S; An SSA; Yu X; Zhang C; Wang H
    Alzheimers Res Ther; 2019 Oct; 11(1):89. PubMed ID: 31651358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease.
    Wang MJ; Yi S; Han JY; Park SY; Jang JW; Chun IK; Kim SE; Lee BS; Kim GJ; Yu JS; Lim K; Kang SM; Park YH; Youn YC; An SSA; Kim S
    Alzheimers Res Ther; 2017 Dec; 9(1):98. PubMed ID: 29246249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ultra-sensitive immunoassay detects and quantifies soluble Aβ oligomers in human plasma.
    Liu L; Kwak H; Lawton TL; Jin SX; Meunier AL; Dang Y; Ostaszewski B; Pietras AC; Stern AM; Selkoe DJ
    Alzheimers Dement; 2022 Jun; 18(6):1186-1202. PubMed ID: 34550630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Amyloid-β Oligomerization as a Biomarker of Alzheimer's Disease: A Blinded Validation Study.
    Youn YC; Lee BS; Kim GJ; Ryu JS; Lim K; Lee R; Suh J; Park YH; Pyun JM; Ryu N; Kang MJ; Kim HR; Kang S; An SSA; Kim S
    J Alzheimers Dis; 2020; 75(2):493-499. PubMed ID: 32310175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous Aβ peptide promote Aβ oligomerization tendency of spiked synthetic Aβ in Alzheimer's disease plasma.
    Choi Y; Joh Y; Ryu JS; Kim K; Seo D; Kim S
    Mol Cell Neurosci; 2021 Mar; 111():103588. PubMed ID: 33422673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers.
    Gandy S; Simon AJ; Steele JW; Lublin AL; Lah JJ; Walker LC; Levey AI; Krafft GA; Levy E; Checler F; Glabe C; Bilker WB; Abel T; Schmeidler J; Ehrlich ME
    Ann Neurol; 2010 Aug; 68(2):220-30. PubMed ID: 20641005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome.
    Schupf N; Patel B; Pang D; Zigman WB; Silverman W; Mehta PD; Mayeux R
    Arch Neurol; 2007 Jul; 64(7):1007-13. PubMed ID: 17620492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF.
    Yang T; Hong S; O'Malley T; Sperling RA; Walsh DM; Selkoe DJ
    Alzheimers Dement; 2013 Mar; 9(2):99-112. PubMed ID: 23375565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
    Kawarabayashi T; Younkin LH; Saido TC; Shoji M; Ashe KH; Younkin SG
    J Neurosci; 2001 Jan; 21(2):372-81. PubMed ID: 11160418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aβ measurement by enzyme-linked immunosorbent assay.
    Schmidt SD; Mazzella MJ; Nixon RA; Mathews PM
    Methods Mol Biol; 2012; 849():507-27. PubMed ID: 22528112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Amyloid Concentration in Alzheimer's Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer's Disease Cases from Controls.
    Feinkohl I; Schipke CG; Kruppa J; Menne F; Winterer G; Pischon T; Peters O
    J Alzheimers Dis; 2020; 74(4):1285-1294. PubMed ID: 32176645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients.
    Svedberg MM; Hall H; Hellström-Lindahl E; Estrada S; Guan Z; Nordberg A; Långström B
    Neurochem Int; 2009; 54(5-6):347-57. PubMed ID: 19162107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of insoluble Amyloid-β with soluble Amyloid-β dimers decreases Amyloid-β plaque numbers.
    van Gerresheim EF; Herring A; Gremer L; Müller-Schiffmann A; Keyvani K; Korth C
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):603-610. PubMed ID: 33338256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum β-amyloid peptide levels spike in the early stage of Alzheimer-like plaque pathology in an APP/PS1 double transgenic mouse model.
    He J; Qiao JP; Zhu S; Xue M; Chen W; Wang X; Tempier A; Huang Q; Kong J; Li XM
    Curr Alzheimer Res; 2013 Nov; 10(9):979-86. PubMed ID: 24117120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study.
    Shah NS; Vidal JS; Masaki K; Petrovitch H; Ross GW; Tilley C; DeMattos RB; Tracy RP; White LR; Launer LJ
    Hypertension; 2012 Apr; 59(4):780-6. PubMed ID: 22392902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of two antibodies to oligomeric Abeta and their use in ELISAs on human brain tissue homogenates.
    van Helmond Z; Heesom K; Love S
    J Neurosci Methods; 2009 Jan; 176(2):206-12. PubMed ID: 18824027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status.
    Babapour Mofrad R; Scheltens P; Kim S; Kang S; Youn YC; An SSA; Tomassen J; van Berckel BNM; Visser PJ; van der Flier WM; Teunissen CE
    Alzheimers Res Ther; 2021 Jul; 13(1):133. PubMed ID: 34311775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.